Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Laezza

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|December 6, 2008
N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1Chiara Laezza, Maria Gabriella Caruso, Teresa Gentile, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Association of Alpha B-Crystallin Expression with Tumor Differentiation Grade in Colorectal Cancer PatientsCristina Pagano, Giovanna Navarra, Patrizia Gazzerro, et al.
Cell Death and Differentiation|October 14, 2017
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic fluxRoberta Ranieri, Elena Ciaglia, Giuseppina Amodio, et al.
Journal of Leukocyte Biology|July 13, 2013
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulationElena Ciaglia, Simona Pisanti, Paola Picardi, et al.
Pharmacological Research|July 27, 2014
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in miceElena Ciaglia, Simona Pisanti, Paola Picardi, et al.
Molecular Pharmacology|September 20, 2008
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinaseIolanda Esposito, Maria Chiara Proto, Patrizia Gazzerro, et al.
Frontiers in Oncology|January 30, 2020
N<sup>6</sup>-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 ExpressionGiovanna Navarra, Cristina Pagano, Roberto Pacelli, et al.
International Journal of Cancer|November 5, 2016
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptorElena Ciaglia, Mario Abate, Chiara Laezza, et al.
International Journal of Molecular Sciences|March 11, 2023
Impacts of Environmental Pollution on Brain TumorigenesisCristina Pagano, Giovanna Navarra, Laura Coppola, et al.
FEBS Open Bio|March 22, 2024
N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activityCristina Pagano, Laura Coppola, Giovanna Navarra, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|December 6, 2008
N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1Chiara Laezza, Maria Gabriella Caruso, Teresa Gentile, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Association of Alpha B-Crystallin Expression with Tumor Differentiation Grade in Colorectal Cancer PatientsCristina Pagano, Giovanna Navarra, Patrizia Gazzerro, et al.
Cell Death and Differentiation|October 14, 2017
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic fluxRoberta Ranieri, Elena Ciaglia, Giuseppina Amodio, et al.
Journal of Leukocyte Biology|July 13, 2013
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulationElena Ciaglia, Simona Pisanti, Paola Picardi, et al.
Pharmacological Research|July 27, 2014
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in miceElena Ciaglia, Simona Pisanti, Paola Picardi, et al.
Molecular Pharmacology|September 20, 2008
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinaseIolanda Esposito, Maria Chiara Proto, Patrizia Gazzerro, et al.
Frontiers in Oncology|January 30, 2020
N<sup>6</sup>-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 ExpressionGiovanna Navarra, Cristina Pagano, Roberto Pacelli, et al.
International Journal of Cancer|November 5, 2016
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptorElena Ciaglia, Mario Abate, Chiara Laezza, et al.
International Journal of Molecular Sciences|March 11, 2023
Impacts of Environmental Pollution on Brain TumorigenesisCristina Pagano, Giovanna Navarra, Laura Coppola, et al.
FEBS Open Bio|March 22, 2024
N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activityCristina Pagano, Laura Coppola, Giovanna Navarra, et al.
Pageof 10